MiraDx to enroll patients for non-tumor based microRNA clinical trial
MicroRNA clinical trial : MiraDx, a Los Angeles-based molecular genetics company, has initiated patient enrollment in collaboration with UCLA for the non-tumor based microRNA biomarker-driven ... Read More
Varian introduces Ethos therapy – AI-powered cancer care delivery solution
Ethos therapy Varian : Varian, a cancer care technologies developer, has introduced Ethos therapy, an artificial intelligence (AI)-powered personalized cancer care delivery system in radiation ... Read More